TSX celebrates largest life sciences IPO by total proceeds raised with market open ceremonyToronto, Ontario--(Newsfile Corp. ...
The company’s shares opened 17% above the offering price before cooling slightly, marking Canada’s biggest initial public ...
Apotex Health Corp. and some of its backers raised C$1.3 billion ($932 million) in a Toronto initial public offering, the ...
Toronto initial public offering, the country’s largest since 2021. The Canadian generic drug manufacturer priced its IPO at ...
1d
Apotex raising IPO size to $1.3-billion on strong investor demand, shares priced at $24, source says
Canada’s largest drug manufacturer, which initially set out to raise $1-billion, will price its shares at $24 each ...
The Canadian Press on MSN
Apotex Health upsizes initial public offering to sell $1.3 billion in shares
Drug company Apotex Health Corp. is increasing the size of its initial public offering to about $1.3 billion, up from its ...
After years of muted new listings, Apotex Health Corp. delivered a strong debut on the Toronto Stock Exchange on Wednesday, offering investors a rare sign of life in Canada’s dormant IPO market and ...
Apotex initially set out to raise $1-billion and hoped to price its shares between $20 and $24 apiece, but the Toronto-based ...
Drug company Apotex Health Corp. has priced its initial public offering at $24 per share. In its final prospectus, the ...
Apotex Health Corp. has commenced trading on the Toronto Stock Exchange (TSX) under the ticker symbol APTX, with its stock ...
The Canadian Press on MSN
Apotex looking to sell about $1 billion in shares in initial public offering
TORONTO — Drug company Apotex Health Corp. says it is looking to sell about $1 billion worth of shares in its initial public ...
CNW/ - ("Apotex") today announced the U.S. launch of sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results